AU4335099A - Surface targeted expression of a modified hepatitis c virus envelope protein - Google Patents

Surface targeted expression of a modified hepatitis c virus envelope protein

Info

Publication number
AU4335099A
AU4335099A AU43350/99A AU4335099A AU4335099A AU 4335099 A AU4335099 A AU 4335099A AU 43350/99 A AU43350/99 A AU 43350/99A AU 4335099 A AU4335099 A AU 4335099A AU 4335099 A AU4335099 A AU 4335099A
Authority
AU
Australia
Prior art keywords
envelope protein
virus envelope
targeted expression
modified hepatitis
surface targeted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43350/99A
Inventor
Jens Bukh
Suzanne U Emerson
Xavier Forns
Robert H. Purcell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU4335099A publication Critical patent/AU4335099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU43350/99A 1998-06-18 1999-06-04 Surface targeted expression of a modified hepatitis c virus envelope protein Abandoned AU4335099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8977998P 1998-06-18 1998-06-18
US60089779 1998-06-18
PCT/US1999/012665 WO1999066033A1 (en) 1998-06-18 1999-06-04 Surface targeted expression of a modified hepatitis c virus envelope protein

Publications (1)

Publication Number Publication Date
AU4335099A true AU4335099A (en) 2000-01-05

Family

ID=22219543

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43350/99A Abandoned AU4335099A (en) 1998-06-18 1999-06-04 Surface targeted expression of a modified hepatitis c virus envelope protein

Country Status (2)

Country Link
AU (1) AU4335099A (en)
WO (1) WO1999066033A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395666B1 (en) 1999-09-29 2002-05-28 Phillips Petroleum Company Organometal catalyst compositions
US20020137022A1 (en) * 2000-08-02 2002-09-26 Min Li Methods and compositions for the construction and use of envelope viruses as display particles
JP5072361B2 (en) * 2004-06-25 2012-11-14 株式会社先端生命科学研究所 HCV RNA with novel sequence
WO2012068637A1 (en) * 2010-11-26 2012-05-31 The Macfarlane Burnet Institute For Medical Research And Public Health Compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610009A (en) * 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
WO1996004301A2 (en) * 1994-07-29 1996-02-15 Chiron Corporation Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
JPH11507129A (en) * 1995-06-07 1999-06-22 アボツト・ラボラトリーズ Detection of antibodies against hepatitis C virus second envelope glycoprotein
AU733719B2 (en) * 1996-10-23 2001-05-24 Trustees Of The University Of Pennsylvania, The Improved vaccines
ES2328536T3 (en) * 1997-05-06 2009-11-13 Novartis Vaccines And Diagnostics, Inc. INTRACELLULAR PRODUCTION OF POLYPEPTIDE E2 TRUNCATED FROM HEPATITIS C.

Also Published As

Publication number Publication date
WO1999066033A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
AU2933797A (en) Synthetic inhibitors of hepatitis c virus ns3 protease
PL324906A1 (en) Vaccines against viral hepatitis of c type
AU5285899A (en) Anti hepatitis c virus antibody and uses thereof
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
PL321966A1 (en) Vaccine against viral hepatitis of b type
AU7063598A (en) Hepatitis c ns3 protease inhibitors
AU5729196A (en) Soluble, active hepatitis c virus protease
AU8740398A (en) Amplification of nucleic acids
AU3714499A (en) Hepatitis c virus mimotopes
ZA9811316B (en) Novel hepatitis C virus NS5B protein
AU2158000A (en) Treatment of hepatitis c virus infections with interleukin-10
AU7602800A (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
AU1629197A (en) Expression of a foamy virus envelope protein
AU2001246331A1 (en) Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
AU5320296A (en) Modified viral envelope polypeptide
EP1141255A4 (en) Modified forms of hepatitis c virus ns3 protease
AU4553697A (en) Immunogenic peptides of foot-and-mouth disease viruses
EP1100545A4 (en) Regulated expression of recombinant proteins using rna viruses
AU4554899A (en) Novel hepatitis c virus peptides and uses thereof
AU4335099A (en) Surface targeted expression of a modified hepatitis c virus envelope protein
AU9494998A (en) (in vivo), animal model for expression of hepatitis c virus
EP1198468A4 (en) Stabilized viral envelope proteins and uses thereof
IL138804A0 (en) Hepatitis c virus ns5b nucleic acids and proteins
AU6221996A (en) Oligonucleotides specific for hepatitis c virus
AU4415099A (en) Inhibition of viral infection and spread with viral and rhoa-derived peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase